Medication info
Ponuvia Tablet 10/100 Milligrams

Ponuvia Tablet 10/100 Milligrams

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tabletDapagliflozin citric acid›14.7mg / 1 tablet
Manufacturer / importer
초당약품공업(주)
Appearance
Yellow, rectangular film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202200493 · Approved 2022.01.28 · Insurance code 670702070

Summary

Main use
Improvement in blood sugar control
Who uses it
Adults
Adult dosage
This medication may be administered to patients taking sitagliptin 100 mg and dapagliflozin 10 mg at a dosage of one tablet once daily, regardless of meals. The tablet should be swallowed whole.

Ingredients

Manufacturer
초당약품공업(주)

Efficacy & effects

Improvement in blood sugar control

View approved original text

This medication helps improve blood sugar control more effectively when used in conjunction with diet and exercise therapy for patients with type 2 diabetes. Sitagliptin and dapagliflozin work together to help manage blood sugar levels more steadily. Therefore, it is an appropriate treatment for individuals who have difficulty controlling their blood sugar. This medication is used to improve your blood sugar control.

Dosage and Administration

Adult dosage

This medication may be administered to patients taking sitagliptin 100 mg and dapagliflozin 10 mg at a dosage of one tablet once daily, regardless of meals. The tablet should be swallowed whole.

Precautions

This medication may cause allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you should stop taking it immediately and consult a doctor. This medication can cause a serious pancreatic condition called pancreatitis, so if you experience symptoms like abdominal pain, nausea, vomiting, or fever while taking it, inform your doctor immediately. Depending on the type of diabetes, this medication should not be taken; patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Patients with lactose intolerance or specific genetic conditions should avoid this medication due to the ingredients it contains. Patients with severely impaired renal function or undergoing dialysis should avoid taking this medication, and those with slightly reduced renal function may require dose adjustments. This medication may lead to symptoms associated with reduced fluid volume, such as dehydration or low blood pressure, so older adults or those taking diuretics should closely monitor their blood pressure and hydration status. There is a risk of hypoglycemia, so when taken with insulin or sulfonylurea medications, blood sugar should be checked frequently, and the dosage of these medications may need to be adjusted if necessary. The risk of genital and urinary tract infections may increase, hence treatment should be sought immediately if infection symptoms occur, and patients with a history of recurrent infections should be especially cautious. Pregnant or breastfeeding women are advised against taking this medication, and it should be discontinued immediately if pregnancy is confirmed. This medication is not recommended for use in children under 18 years old as safety and efficacy have not been established. In case of overdose, there is no specific antidote, but appropriate treatment should be administered based on symptoms, with monitoring in a hospital if necessary. Caution is advised when driving or operating machinery due to the risk of hypoglycemia, so one should be careful when symptoms occur.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), anaphylaxis, angioedema, severe skin reactions (Stevens-Johnson syndrome, exfoliative skin disease, bullous pemphigoid), acute pancreatitis, hemorrhagic or necrotizing pancreatitis, severe hypoglycemia, acute kidney failure, deterioration of kidney function, ketoacidosis (including diabetic ketoacidosis), urosepsis, pyelonephritis, fulminant necrosis (Fournier's gangrene), severe headache, seizures, altered consciousness, visual disturbances,

Mild side effects

  • Headache
  • upper respiratory infection
  • nasopharyngitis
  • constipation
  • dry mouth
  • back pain
  • urinary pain
  • polyuria
  • nocturia
  • itching of the vulva
Show 25 more
  • genital itching
  • dizziness
  • weight loss
  • increased serum creatinine
  • increased blood urea
  • dyslipidemia
  • diaphoresis
  • pruritus
  • nausea
  • diarrhea
  • dyspepsia
  • abdominal pain
  • malaise
  • vomiting
  • reduced blood pressure
  • palpitations
  • insomnia
  • tinnitus
  • fatigue
  • weakness
  • menstrual irregularities
  • vaginal discharge
  • myalgia
  • arthralgia
  • limbs

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is advisable to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, rectangular film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.